Analystreport

NeuBase Therapeutics (NASDAQ: NBSE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating.

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report